ClinVar Miner

Submissions for variant NM_001014.5(RPS10):c.71A>G (p.Lys24Arg)

gnomAD frequency: 0.00007  dbSNP: rs201147592
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000309035 SCV000462637 likely benign Diamond-Blackfan anemia 9 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Baylor Genetics RCV000309035 SCV001481486 uncertain significance Diamond-Blackfan anemia 9 2019-01-20 criteria provided, single submitter clinical testing This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].
Invitae RCV001493828 SCV001698468 likely benign Diamond-Blackfan anemia 2024-01-28 criteria provided, single submitter clinical testing
Ambry Genetics RCV001493828 SCV002668557 likely benign Diamond-Blackfan anemia 2017-07-06 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Ambry Genetics RCV002523566 SCV003680953 uncertain significance Inborn genetic diseases 2021-10-21 criteria provided, single submitter clinical testing The c.71A>G (p.K24R) alteration is located in exon 2 (coding exon 1) of the RPS10-NUDT3 gene. This alteration results from a A to G substitution at nucleotide position 71, causing the lysine (K) at amino acid position 24 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.